The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
August 21st 2025
The oral glucagon-like peptide agonist-1 met its primary end point and all secondary end points in a randomized, double-blind, placebo-controlled clinical trial for weight management.
FDA Approves Avacopan for Treatment of ANCA-Associated Vasculitis
October 8th 2021Avacopan (Tavneos, ChemoCentryx) met its primary endpoints of disease remission at 26 weeks and sustained remission at 52 weeks during a phase 3 trial in patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Read More